Boston, MA 05/27/2014 (wallstreetpr) – Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has reported a structural change in the team of its chiefs with the addition of a new name. This could be revolutionary step for the company, as it not only marks the addition of a new member to the management but also the commencement of a new post, that of a Chief Operating Officer. Jazz also revealed through a recent press release that the company would be attending an important investor conference soon.
The new chief
Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has announced the creation of the new position of the Chief Operating Officer and has appointed Russell J. Cox as the COO. Prior to this appointment, Mr. J. Cox had been serving Jazz as the Chief Commercial Officer and Executive Vice President. His job description now involves the handling and managing of technical operations, Research & Development and commercial organizations at the global level.
M. J. Cox has been a part of Jazz since the year 2010. The company has reported that Mr. Cox has more than 20 years of experience in leading biopharmaceutical companies at the global level, which would prove to be beneficial for Jazz.
Before coming to Jazz, Mr. Cox was the Chief Commercial Officer and senior Vice President at Ipsen Group and also served at one point as the Chief Marketing Officer of Scios, Inc. He joined the Board of Vascular Cures in 2013 as a director. The company also reported that Mr. Cox is also the member of the Executive Committee at Harvard for the Medical School Division of Sleep Medicine. The experience that Mr. Cox possesses in different specialty areas is invaluable, the company reports. Reportedly, Mr. Cox is excited to take over the post of the COO at Jazz.
The Chief Executive Officer of Jazz, Bruce Cozzad said that this was the apt time to create the post of the COO as it might prove crucial to the management of the expanding global operations of Jazz Pharmaceuticals.
The upcoming investor conference
Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) would be giving a presentation at the Goldman Sachs 35th Annual Global Healthcare Conference to be held on June 10, 2014 in Rancho Palos Verdes. The company would reveal its future plans and strategies that might help the investors to comprehend the upcoming moves of Jazz Pharmaceuticals. A live audio webcast would be available for the access of investors under the Investors Section on the official website of the company.